Dr. Nelli Bejanyan, MD
Claim this profileMoffitt Cancer Center
Studies Acute Myeloid Leukemia
Studies Acute Myelogenous Leukemia
10 reported clinical trials
14 drugs studied
Area of expertise
1Acute Myeloid Leukemia
T315I positive
Stage I
Stage II
2Acute Myelogenous Leukemia
T315I positive
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Nelli Bejanyan, MD is currently running
Vitamin A
for Graft-versus-Host Disease
The investigators hypothesize that single oral high dose supplementation with vitamin A will reduce the incidence of moderate-severe chronic graft-versus-host disease (GVHD) compared with placebo.
Recruiting0 awards Phase 23 criteria
Ruxolitinib vs Prednisone
for Graft-versus-Host Disease
Allogeneic transplant is potentially curative for hematological malignancies but its use is limited by the development of GVHD. Ruxolitinib now has FDA approval for treatment of chronic GVHD that has failed 1-2 prior lines of therapy based on a prior large, randomized phase III study. Given this evidence of safety and efficacy in the early refractory setting (after prednisone failure), Ruxolitinib represents an ideal agent to test in the primary therapy setting. Here investigators propose a phase 2 randomized study to compare Ruxolitinib to prednisone as a first-line therapy in the treatment of chronic GVHD.
Recruiting1 award Phase 23 criteria
More about Nelli Bejanyan, MD
Clinical Trial Related3 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Nelli Bejanyan, MD has experience with
- Fludarabine
- Melphalan
- Total Body Irradiation
- Gamma Delta T-Cell Infusion
- CD8 Depleted, Non-engrafting,HLA Mismatched Unrelated Donor Lymphocytes
- Standard Of Care Chemotherapy
Breakdown of trials Nelli Bejanyan, MD has run
Acute Myeloid Leukemia
Acute Myelogenous Leukemia
Myelodysplastic Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nelli Bejanyan, MD specialize in?
Nelli Bejanyan, MD focuses on Acute Myeloid Leukemia and Acute Myelogenous Leukemia. In particular, much of their work with Acute Myeloid Leukemia has involved T315I positive patients, or patients who are Stage I.
Is Nelli Bejanyan, MD currently recruiting for clinical trials?
Yes, Nelli Bejanyan, MD is currently recruiting for 3 clinical trials in Tampa Florida. If you're interested in participating, you should apply.
Are there any treatments that Nelli Bejanyan, MD has studied deeply?
Yes, Nelli Bejanyan, MD has studied treatments such as Fludarabine, Melphalan, Total Body Irradiation.
What is the best way to schedule an appointment with Nelli Bejanyan, MD?
Apply for one of the trials that Nelli Bejanyan, MD is conducting.
What is the office address of Nelli Bejanyan, MD?
The office of Nelli Bejanyan, MD is located at: Moffitt Cancer Center, Tampa, Florida 33612 United States. This is the address for their practice at the Moffitt Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.